Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production
Jaemeun Lee, … , Yong Chul Bae, Eun-Kyoung Kim
Jaemeun Lee, … , Yong Chul Bae, Eun-Kyoung Kim
Published July 9, 2020
Citation Information: JCI Insight. 2020;5(16):e135412. https://doi.org/10.1172/jci.insight.135412.
View: Text | PDF
Research Article Endocrinology Neuroscience

Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production

  • Text
  • PDF
Abstract

Evidence has mounted that insulin can be synthesized in various brain regions, including the hypothalamus. However, the distribution and functions of insulin-expressing cells in the hypothalamus remain elusive. Herein, we show that in the mouse hypothalamus, the perikarya of insulin-positive neurons are located in the paraventricular nucleus (PVN) and their axons project to the median eminence; these findings define parvocellular neurosecretory PVN insulin neurons. Contrary to corticotropin-releasing hormone expression, insulin expression in the PVN was inhibited by restraint stress (RS) in both adult and young mice. Acute RS–induced inhibition of PVN insulin expression in adult mice decreased both pituitary growth hormone (Gh) mRNA level and serum GH concentration, which were attenuated by overexpression of PVN insulin. Notably, PVN insulin knockdown or chronic RS in young mice hindered normal growth via the downregulation of GH gene expression and secretion, whereas PVN insulin overexpression in young mice prevented chronic RS–induced growth retardation by elevating GH production. Our results suggest that in both normal and stressful conditions, insulin synthesized in the parvocellular PVN neurons plays an important role in the regulation of pituitary GH production and body length, unveiling a physiological function of brain-derived insulin.

Authors

Jaemeun Lee, Kyungchan Kim, Jae Hyun Cho, Jin Young Bae, Timothy P. O’Leary, James D. Johnson, Yong Chul Bae, Eun-Kyoung Kim

×

Figure 3

Insulin synthesis in the PVN is suppressed by acute RS.

Options: View larger image (or click on image) Download as PowerPoint
Insulin synthesis in the PVN is suppressed by acute RS.
(A and B) Time c...
(A and B) Time course study of hypothalamic Crh (A) and Ins2 (B) mRNA expression after acute RS from 15 minutes to 8 hours. Data are shown as mean ± SEM, 1-way ANOVA with Bonferroni’s post hoc tests. **P < 0.01, ***P < 0.001, n = 5–7 mice/group. (C) Effects of acute RS for 8 hours (RS 8 h) on the relative levels of Crh and Ins2 mRNA in the microdissected PVN. (D–H) Confocal images of the PVN and ME and quantitative analysis of the positive cell number and fluorescence intensity. PVN sections triple immunostained for proinsulin, CRH, and the neuronal activity marker c-Fos (D). ME sections double immunostained for C-peptide and CRH (E). The percentage of proinsulin+CRH+ cells coexpressing c-Fos (F). Fluorescence intensity of proinsulin- or CRH-immunoreactive cells in the PVN (G) and of C-peptide– or CRH-immunoreactive nerve terminals in the ME (H). Data are shown as mean ± SEM, 2-tailed unpaired Student’s t test. **P < 0.01, *** and ###P < 0.001, n = 9 mice/group (C), n = 4 mice/group (F–H). Scale bars: 50 μm. No RS, no restraint stress group; RS, restraint stress group.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts